ZA953701B - New atagonist compounds - Google Patents
New atagonist compoundsInfo
- Publication number
- ZA953701B ZA953701B ZA953701A ZA953701A ZA953701B ZA 953701 B ZA953701 B ZA 953701B ZA 953701 A ZA953701 A ZA 953701A ZA 953701 A ZA953701 A ZA 953701A ZA 953701 B ZA953701 B ZA 953701B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- atagonist
- compounds
- new
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9401728A SE9401728D0 (sv) | 1994-05-18 | 1994-05-18 | New compounds II |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA953701B true ZA953701B (en) | 1995-11-20 |
Family
ID=20394059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA953701A ZA953701B (en) | 1994-05-18 | 1995-05-08 | New atagonist compounds |
Country Status (11)
Country | Link |
---|---|
US (1) | US6136817A (sv) |
EP (1) | EP0759922B1 (sv) |
JP (1) | JP4117801B2 (sv) |
AT (1) | ATE259815T1 (sv) |
AU (1) | AU690996B2 (sv) |
DE (1) | DE69532580T2 (sv) |
ES (1) | ES2214501T3 (sv) |
IL (1) | IL113631A0 (sv) |
SE (1) | SE9401728D0 (sv) |
WO (1) | WO1995031463A1 (sv) |
ZA (1) | ZA953701B (sv) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU712012B2 (en) * | 1995-09-26 | 1999-10-28 | Toray Industries, Inc. | Indole derivatives and medical application thereof |
US5994327A (en) * | 1995-11-17 | 1999-11-30 | Astra Ab | Process for the preparation of morphinans |
CA2269910A1 (en) * | 1996-11-19 | 1998-05-28 | Zhong-Yong Wei | New process for the preparation of morphinans |
US6156762A (en) * | 1997-01-16 | 2000-12-05 | Toray Industries, Inc. | Indolomorphinan derivative and agent for curing and preventing cerebral disorder |
DE19939044A1 (de) * | 1999-08-18 | 2001-03-15 | Gruenenthal Gmbh | Verwendung von Morphinanderivaten als Arzneimittel |
AU2003217436A1 (en) * | 2002-02-15 | 2003-09-09 | Howard Brooks-Korn | Use of opioid compound to treat a neurologic or neurogenic disorder |
DE10229842A1 (de) * | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
ATE444295T1 (de) | 2002-11-08 | 2009-10-15 | Mallinckrodt Inc | Verfahren zur herstellung von quaternäre n-alkyl morphinan alkaloid salzen |
EP1595541A1 (en) * | 2004-05-12 | 2005-11-16 | Alcasynn Pharmaceuticals Gmbh | Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
CA2571710A1 (en) | 2004-06-24 | 2006-11-02 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
JPWO2006064779A1 (ja) * | 2004-12-14 | 2008-06-12 | 塩野義製薬株式会社 | 6’位にカルボキシを有するインドロモルヒナン誘導体 |
EP2012686B1 (en) * | 2006-04-18 | 2013-10-02 | Joseph Nicholas Logan | Spinal rod system |
CA2663909A1 (en) * | 2006-09-20 | 2008-03-27 | Mallinckrodt Inc. | Preparation of substituted morphinan-6-ones and salts and intermediates thereof |
US9040726B2 (en) * | 2007-03-06 | 2015-05-26 | Mallinckrodt Llc | Process for the preparation of quaternary N-alkyl morphinan alkaloid salts |
CA2707757C (en) * | 2007-03-06 | 2017-01-03 | Peter X. Wang | Process for the preparation of quaternary n-alkyl morphinan alkaloid salts |
EP2214672B1 (en) * | 2007-10-18 | 2012-10-17 | Aiko Biotechnology | Combination analgesic employing opioid and neutral antagonist |
US8748448B2 (en) | 2007-10-18 | 2014-06-10 | Aiko Biotechnology | Combination analgesic employing opioid agonist and neutral antagonist |
ES2569655T3 (es) | 2007-12-17 | 2016-05-12 | Mallinckrodt Llc | Procedimientos para la producción de compuestos de (+)-'nal' morfinano |
WO2009132313A2 (en) * | 2008-04-25 | 2009-10-29 | Progenics Pharmaceuticals, Inc. | Morphinan derivatives of organic and inorganic acids |
AU2009251427B2 (en) * | 2008-05-27 | 2014-05-22 | SpecGx LLC | Processes and compounds for the preparation of normorphinans |
WO2010028004A2 (en) | 2008-09-03 | 2010-03-11 | Mallinckrodt Inc. | Substituted berbines and processes for their synthesis |
EP2340832A1 (en) | 2009-12-23 | 2011-07-06 | Universität Innsbruck | Morphinan-6-one compounds for the treatment or prevention of neurodegenerative diseases |
WO2014136305A1 (ja) * | 2013-03-08 | 2014-09-12 | 学校法人北里研究所 | モルヒナン誘導体 |
US9969746B2 (en) | 2013-12-05 | 2018-05-15 | The University Of Bath | Opioid compounds and their uses |
WO2020012245A1 (en) | 2018-07-13 | 2020-01-16 | Alkermes Pharma Ireland Limited | Thienothiophene-naltrexone prodrugs for long-acting injectable compositions |
US10799496B2 (en) | 2018-07-13 | 2020-10-13 | Alkermes Pharma Ireland Limited | Naphthylenyl compounds for long-acting injectable compositions and related methods |
WO2020094634A1 (en) | 2018-11-05 | 2020-05-14 | Alkermes Pharma Ireland Limited | Thiophene prodrugs of naltroxene for long-acting injectable compositions and related methods |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816586A (en) * | 1987-07-29 | 1989-03-28 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
JP2906654B2 (ja) * | 1989-11-28 | 1999-06-21 | 東レ株式会社 | 免疫抑制剤及びその製造方法 |
JPH04342529A (ja) * | 1991-05-21 | 1992-11-30 | Toray Ind Inc | 抗アレルギー剤 |
US5225417A (en) * | 1992-01-21 | 1993-07-06 | G. D. Searle & Co. | Opioid agonist compounds |
US5223507A (en) * | 1992-01-21 | 1993-06-29 | G. D. Searle & Co. | Method of using opioid compounds as delta opioid selective agonist analgesics |
ATE239732T1 (de) * | 1992-09-29 | 2003-05-15 | Toray Industries | Indol-derivat, verfahren zu dessen herstellung und dessen medizinische anwendung |
-
1994
- 1994-05-18 SE SE9401728A patent/SE9401728D0/sv unknown
-
1995
- 1995-05-07 IL IL11363195A patent/IL113631A0/xx unknown
- 1995-05-08 ZA ZA953701A patent/ZA953701B/xx unknown
- 1995-05-09 DE DE69532580T patent/DE69532580T2/de not_active Expired - Lifetime
- 1995-05-09 EP EP95920328A patent/EP0759922B1/en not_active Expired - Lifetime
- 1995-05-09 WO PCT/SE1995/000503 patent/WO1995031463A1/en active IP Right Grant
- 1995-05-09 AU AU25817/95A patent/AU690996B2/en not_active Ceased
- 1995-05-09 ES ES95920328T patent/ES2214501T3/es not_active Expired - Lifetime
- 1995-05-09 AT AT95920328T patent/ATE259815T1/de not_active IP Right Cessation
- 1995-05-09 JP JP52955395A patent/JP4117801B2/ja not_active Expired - Fee Related
- 1995-05-09 US US08/507,369 patent/US6136817A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU690996B2 (en) | 1998-05-07 |
EP0759922B1 (en) | 2004-02-18 |
SE9401728D0 (sv) | 1994-05-18 |
JPH10500131A (ja) | 1998-01-06 |
WO1995031463A1 (en) | 1995-11-23 |
EP0759922A1 (en) | 1997-03-05 |
ES2214501T3 (es) | 2004-09-16 |
ATE259815T1 (de) | 2004-03-15 |
AU2581795A (en) | 1995-12-05 |
DE69532580T2 (de) | 2004-07-29 |
JP4117801B2 (ja) | 2008-07-16 |
US6136817A (en) | 2000-10-24 |
IL113631A0 (en) | 1995-08-31 |
DE69532580D1 (de) | 2004-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA953701B (en) | New atagonist compounds | |
AU649115B2 (en) | New heterocycle-substituted alkylamides, process for preparing them and pharmaceutical compositions containing them | |
EG19361A (en) | A process for the preparation of piperidine compound having local anaesthetica and analgetic | |
MX9603092A (es) | Nuevos compuestos con efecto analgesico y anestesico local. | |
LTIP1958A (en) | New use of ropivacaine | |
AU6519596A (en) | Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases | |
SE9401596D0 (sv) | New compounds | |
CA2189140A1 (en) | New antagonist compounds | |
MX9605604A (es) | Nuevos compuestos agonistas. | |
JO1652B1 (en) | New compounds for local anesthesia and a way to prepare them | |
JO1658B1 (en) | New vehicles | |
NZ304823A (en) | Beta carboline derivatives and medicaments |